Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis

The high variability and unpredictability of the plasma concentration of voriconazole (VRC) pose a major challenge for clinical administration. The aim of this study was to develop a population pharmacokinetics (PPK) model of VRC and identify the factors influencing VRC PPK in patients with talaromy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhiwen, Wei, Yinyi, Huang, Weie, Li, Bingkun, Zhou, Siru, Liao, Liuwei, Li, Tiantian, Liang, Tianwei, Yu, Xiaoshu, Li, Xiuying, Zhou, Changjing, Cao, Cunwei, Liu, TaoTao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549404/
https://www.ncbi.nlm.nih.gov/pubmed/36225581
http://dx.doi.org/10.3389/fphar.2022.982981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549404/
https://www.ncbi.nlm.nih.gov/pubmed/36225581
http://dx.doi.org/10.3389/fphar.2022.982981

Ejemplares similares